Impact of Label Restriction on Checkpoint-Inhibitor Use in Bladder Cancer and Changes in Mortality

Overview of attention for article published in JNCI Cancer Spectrum, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 26,085 followers.

RT @JNCI_Now: Now in @JNCI_Now #CancerSpectrum, Vader et al analyzed a national electronic health record dataset to assess the impact on su…

Now in @JNCI_Now #CancerSpectrum, Vader et al analyzed a national electronic health record dataset to assess the impact on survival outcomes of the FDA label change to limit use of immune checkpoint inhibitors in metastatic bladder cancer. Read more her…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.